I would say generally that's one of the challenges. First of all, even having the data available is a challenge. Then, of course, there's finding a way of sharing it.
One of the challenges that exists with prescription drug abuse information is that it's not collected in every jurisdiction. In the jurisdictions where it is collected, it's not always collected in the same manner. This is one of the key areas of focus, the information gaps and the sharing of that information, and collecting that information in a way that is uniform and consistent so that it can therefore be used to compare and to come up with interventions.
That is one of the challenges. I think that's something we would look at working into the introduction of prescription drug abuse activities under the national anti-drug strategy.